Instil Bio (TIL) Operating Income (2020 - 2026)
Instil Bio (TIL) posted quarterly Operating Income of -$7.0 million for Q1 2026, up 77.06% year-over-year from -$4.0 million in Q1 2025, and up 26.65% quarter-over-quarter from -$9.6 million in Q4 2025.
Instil Bio (TIL) Operating Income (2020 - 2026) Analysis & Trends
Instil Bio's Operating Income history runs 7 years deep, the most recent figure standing at -$7.0 million for Q1 2026.
- In Q1 2026, Operating Income rose 77.06% year-over-year to -$7.0 million; the TTM figure through Mar 2026 stood at -$55.0 million (up 31.34% YoY), while the FY2025 annual figure was -$78.6 million, down 6.85% from the prior year.
- Operating Income for Q1 2026 stood at -$7.0 million, up from -$9.6 million in the prior quarter.
- The five-year high for Operating Income was -$7.0 million in Q1 2026, with the low at -$66.7 million in Q3 2023.
- The 5-year median for Operating Income is -$23.6 million (2024), against an average of -$32.0 million.
- The sharpest annual moves came in 2022 and 2023: Operating Income tumbled 131.96% in 2022, then jumped 77.08% in 2023.
- Instil Bio's Operating Income stood at -$56.8 million in 2022, then surged by 77.08% to -$13.0 million in 2023, then climbed by 9.22% to -$11.8 million in 2024, then climbed by 19.14% to -$9.6 million in 2025, then increased by 26.65% to -$7.0 million in 2026.
- Business Quant data shows TIL's Operating Income at -$7.0 million in Q1 2026, -$9.6 million in Q4 2025, and -$15.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 140.01 Bn | 132.16 Bn | 2.84 Bn | 1.25 Bn |
| 2 | Regeneron Pharmaceuticals | 86.79 Bn | 78.79 Bn | 3.93 Bn | 1.29 Bn |
| 3 | Argenx Se | 65.29 Bn | 60.11 Bn | 1.37 Bn | 493.00 Mn |
| 4 | Moderna | 60.18 Bn | 55.04 Bn | 52.00 Mn | -815.00 Mn |
| 5 | BeOne Medicines | 42.17 Bn | 37.07 Bn | 1.53 Bn | 325.05 Mn |
| 6 | Alnylam Pharmaceuticals | 31.55 Bn | 28.24 Bn | 992.69 Mn | 231.44 Mn |
| 7 | BioNTech SE | 28.45 Bn | 10.06 Bn | 668.28 Mn | -375.75 Mn |
| 8 | Insmed | 27.45 Bn | 26.29 Bn | 358.27 Mn | -1.55 Mn |
| 9 | Royalty Pharma | 27.19 Bn | 26.36 Bn | - | 133.12 Mn |
| 10 | Instil Bio | 53.44 Mn | 53.44 Mn | - | -5.58 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -5.58 Mn |
| Mar 31, 2026 | -7.01 Mn |
| Dec 31, 2025 | -9.56 Mn |
| Sep 30, 2025 | -15.02 Mn |
| Jun 30, 2025 | -23.44 Mn |
| Mar 31, 2025 | -30.56 Mn |
| Dec 31, 2024 | -11.82 Mn |
| Sep 30, 2024 | -23.63 Mn |
| Jun 30, 2024 | -14.14 Mn |
| Mar 31, 2024 | -23.96 Mn |
| Dec 31, 2023 | -13.02 Mn |
| Sep 30, 2023 | -66.72 Mn |
| Jun 30, 2023 | -20.99 Mn |
| Mar 31, 2023 | -58.45 Mn |
| Dec 31, 2022 | -56.80 Mn |
| Sep 30, 2022 | -56.65 Mn |
| Jun 30, 2022 | -58.72 Mn |
| Mar 31, 2022 | -54.29 Mn |
| Dec 31, 2021 | -53.75 Mn |
| Sep 30, 2021 | -43.02 Mn |